Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

Glow Blend (GHK-Cu, BPC-157, TB-500) Dosage Guide, Benefits & Side Effects

Glow Blend (GHK-Cu, BPC-157, TB-500) Dosage Guide, Benefits & Side Effects This collagen and tissue-repair stack combines three peptides for faster wound healing, firmer skin, and musculoskeletal recovery. As seen on Glow Blend (GHK-Cu, BPC-157, TB-500) Dosage

Glow Blend (GHK-Cu, BPC-157, TB-500) Dosage Guide, Benefits & Side Effects

This collagen and tissue-repair stack combines three peptides for faster wound healing, firmer skin, and musculoskeletal recovery.

As seen on

Glow Blend (GHK-Cu, BPC-157, TB-500) Dosage Guide for Longevity & Anti-AgingGlow Blend (GHK-Cu, BPC-157, TB-500) Dosage Calculator

This blend combines GHK-Cu, BPC-157, and TB-500 to support skin health alongside general tissue repair. How much you take depends on the amount of GHK-Cu in the specific product.

Vial size

35 mg

Bacteriostatic water

3–5 mL

Dosing

1–3 mg

Frequency

5 days on / 2 days off

Cycle

6–8 weeks

Benefit

Longevity & Anti-Aging

What is Glow Blend (GHK-Cu, BPC-157, TB-500)?

Glow Blend is a combination of three well-known research peptides (GHK-Cu, BPC-157, and TB-500) mixed together to work on skin and tissue repair from multiple angles at once. GHK-Cu boosts collagen and skin renewal, BPC-157 supports healing and blood vessel growth, and TB-500 helps cells move to where repair is needed. It's used in research and wellness settings for faster healing, skin rejuvenation, and recovery from musculoskeletal injuries.

Healing

Research targets include tissue repair, wound healing, and recovery from injury.

Skin

Research targets include collagen production, skin elasticity, and hair follicle health.

glow

Is Glow Blend (GHK-Cu, BPC-157, TB-500) FDA approved?

Glow Blend (GHK-Cu, BPC-157, TB-500) is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.

Research Use Only

Glow Blend (GHK-Cu, BPC-157, TB-500) has not been evaluated by the FDA for safety or efficacy in humans.

No Clinical Oversight

Not manufactured under FDA-regulated quality or clinical standards.

Unregulated Sourcing

Purity, dosing, and sourcing are not verified through FDA testing or oversight.

Our top-rated vendor

View all vendors

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health

#1 Rated Research Peptide Supplier

How Does Glow Blend (GHK-Cu, BPC-157, TB-500) Work?

GHK-Cu boosts collagen-building enzymes in the skin; BPC-157 switches on blood-vessel-growth signals and calms inflammation at the site of injury; and TB-500 grabs onto a cell's internal scaffolding protein (actin) to help cells move quickly to where they're needed. Combined, the three peptides support tissue repair from different angles at once.

Builds collagen

GHK-Cu boosts collagen-building enzymes in the skin.

Grows new vessels

BPC-157 switches on blood-vessel-growth signals and calms inflammation.

Speeds cell movement

TB-500 helps cells move quickly to where they're needed.

Glow Blend (GHK-Cu, BPC-157, TB-500) Targeted areas

How to reconstitute Glow Blend (GHK-Cu, BPC-157, TB-500)

The materials you'll need and step-by-step instructions for safely mixing Glow Blend (GHK-Cu, BPC-157, TB-500) with bacteriostatic water.

Materials needed

Your Glow Blend (GHK-Cu, BPC-157, TB-500) vial (lyophilized)

Alcohol swabs

Bacteriostatic sterile water

3 mL syringes (Luer Lock tip)

25G or 27G needles (Luer Lock). Other gauges may also be acceptable.

Sharps container (optional)

Remove the caps

Sanitize the rubber stoppers

Attach the needle

Draw the bac water

Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.

Insert the needle into the Glow Blend (GHK-Cu, BPC-157, TB-500) vial

With the bac water in your syringe, insert the needle into the Glow Blend (GHK-Cu, BPC-157, TB-500) vial at a slight angle to avoid pressure buildup.

Release the water gently

Let the water run gently down the side of the vial. Don't inject it forcefully.

Swirl to dissolve

Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.

Check for full dissolution

Cap, dispose, and store

How to Store Glow Blend (GHK-Cu, BPC-157, TB-500)

Freeze the dry powder for long-term storage, or refrigerate it for up to four weeks. Once mixed with 3mL of bacteriostatic water, refrigerate and use within about a month, kept away from light.

Lyophilized Storage

-20°C long-term or 2–8°C for up to 4 weeks.

Reconstituted Storage

With 3mL bacteriostatic water, refrigerate at 2–8°C and use within 28 days.

Handling Notes

Protect from light.

What Are the Benefits of Glow Blend (GHK-Cu, BPC-157, TB-500)?

What research says it may help with, and how it works in the body.

primary applications

The three ingredients are thought to work better together than alone, but formal studies testing this combination are still limited.

The GHK-Cu ingredient stimulates the body to produce more collagen, a key protein for skin and connective tissue.

The BPC-157 and TB-500 ingredients in the blend help support the regrowth and repair of tissue.

What Are the Side Effects of Glow Blend (GHK-Cu, BPC-157, TB-500)?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Stop Right Away If You Notice

Severe injection site reactions or infection

Allergic reactions (rash, difficulty breathing)

Signs of copper toxicity (nausea, jaundice)

Milder Signs to Watch For

Glow Blend (GHK-Cu, BPC-157, TB-500) contains these peptides

The individual peptides blended together to make Glow Blend (GHK-Cu, BPC-157, TB-500).

bpc

Longevity

BPC-157

Preclinical

ghk

GHK-Cu

Experimental

tb5

TB-500

How Long Should a Glow Blend (GHK-Cu, BPC-157, TB-500) Cycle Last?

This breaks down how long a typical Glow Blend (GHK-Cu, BPC-157, TB-500) cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Related peptides

Growth

ghr

GHRP-2

Approved

ghrp

GHRP-6

Phase 1

hex

Hexarelin

Phase 2

ipa

Ipamorelin

Cheat Sheets Featuring Glow Blend (GHK-Cu, BPC-157, TB-500)

See how Glow Blend (GHK-Cu, BPC-157, TB-500) fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.

18 peptides

42 peptides

78 peptides

7 peptides

Browse user-created protocols

Real protocols from the community that include Glow Blend (GHK-Cu, BPC-157, TB-500)

Dr. JRSW

Jana

nad

Weight

GLP-3

Glow Blend (GHK-Cu, BPC-157, TB-500) Research References

It is a preclinical compound

Glow Blend (GHK-Cu, BPC-157, TB-500)

Glow Blend (GHK-Cu, BPC-157, TB-500) is a preclinical compound

Dose range 250-500mcg daily shows wound healing and anti-inflammatory properties

n.d.

Demonstrates collagen stimulation and skin improvement at 1-2mg daily doses

Shows tissue regeneration effects at 2-5mg twice weekly dosing

Frequently Asked Questions About Glow Blend (GHK-Cu, BPC-157, TB-500)

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

What is the Glow Blend and what does each peptide do?

Glow Blend is a combination product sold by research-peptide vendors that puts three peptides in a single vial: BPC-157, TB-500 (a thymosin beta-4 fragment), and GHK-Cu (a copper-binding peptide). Each is associated with a different mechanism: BPC-157 is studied for supporting blood vessel growth (angiogenesis) and gut, tendon, and ligament repair; TB-500 is studied for promoting cell migration and systemic tissue healing; and GHK-Cu is studied for its role in collagen and elastin production and skin/tissue remodeling. The rationale for combining them is that they target complementary parts of a healing and tissue-remodeling process, though no published human trial has evaluated the three compounds together as a fixed combination.

How is Glow Blend typically dosed and reconstituted?

Vendor and community protocols commonly describe a 70 mg lyophilized vial reconstituted with about 3 mL of bacteriostatic water, added by directing the stream against the vial wall (not directly onto the powder) and gently rolling rather than shaking, yielding roughly a 23 mg/mL solution. Community-reported daily subcutaneous doses are often around 10 units (0.10 mL), delivering approximately 1.67 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection. When the peptides are run from separate vials instead of a pre-blend, reported ranges include BPC-157 at roughly 250-500 mcg/day, TB-500 at roughly 2.5-5 mg twice weekly, and GHK-Cu at roughly 1-2 mg/day, each injected with its own syringe rather than mixed together. These figures come from vendor and community sources rather than clinical dosing studies, and no standardized human dose has been established.

How long is a typical cycle, and can it be run continuously?

Community protocols generally describe cycles of about 4-6 weeks on followed by 2-4 weeks off, with some extended protocols running 8-12 weeks on and 4-8 weeks off. The off-period is often tied to GHK-Cu "copper cycling" recommendations rather than to BPC-157 or TB-500 specifically. There is no clinically validated cycle length, and these schedules reflect anecdotal and vendor guidance rather than established research protocols.

What side effects have been reported?

Commonly reported effects include mild injection-site irritation (redness, itching, or soreness), short-term fatigue (particularly reported during TB-500 loading phases), and occasional headache. Because BPC-157 and TB-500 both influence angiogenic (blood vessel growth) signaling, sources caution that the combination may be unsuitable for people with active cancer or vascular conditions. These reports come from user and vendor sources rather than controlled clinical trials, so the full side-effect profile, especially with long-term or repeated use, is not well characterized.

How should Glow Blend be stored?

Unreconstituted (lyophilized powder) is generally recommended to be stored frozen for longer-term storage, though some sources note it can remain stable for a few months at room temperature if sealed and kept away from light. Once reconstituted, it should be refrigerated (roughly 2-8°C / 35-46°F) and not frozen; reported stability after mixing ranges from about 1-2 weeks (TB-500 tends to degrade faster) up to about 30 days for the blend overall. Vendors generally recommend only reconstituting the amount you intend to use in that timeframe.

Is Glow Blend legal, and is it approved for human use?

Glow Blend and its individual components are not approved by the FDA for human use and are sold by research chemical suppliers labeled strictly for laboratory or research purposes, not for human consumption. BPC-157 and TB-500 are also on the World Anti-Doping Agency's prohibited list for athletes. Because these are unregulated compounds, there is no guarantee of pharmaceutical-grade purity, dosing accuracy, or sterility from any given supplier, and published safety and efficacy data in humans is limited.

Can Glow Blend be stacked with other peptides or treatments?

Some vendors describe extending the stack by adding a fourth peptide, KPV, for additional anti-inflammatory coverage (sometimes marketed as a "KLOW" stack). Aesthetic and wellness clinics also describe combining GHK-Cu-containing protocols with procedures like facials, lasers, or other injectables as part of a broader skin-focused regimen. As with dosing, these combinations are based on vendor and community practice rather than controlled studies, and any decision to combine compounds carries added uncertainty about interactions and cumulative side effects.

How quickly do people report seeing results?

Reported timelines vary by which effect is being tracked: recovery- or repair-related effects (attributed to BPC-157 and TB-500) are sometimes reported sooner, while skin- and tissue-quality changes attributed to GHK-Cu are generally described as gradual, with visible changes typically judged over weeks to months rather than days. These are self-reported or vendor-described timelines, not results from controlled clinical measurement.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Research Models Best Suited for KLOW Stack Combination Studies

Based on the mechanistic profiles above, the KLOW Stack's synergistic interactions are most clearly testable in: Full-thickness wound healing models — where angiogenesis, ECM remodeling, inflammation resolution, and re-epithelialization occur sequentially and can be temporally dissected. DSS-induced colitis models — where BPC-157's cytoprotective and KPV's immunomodulatory mechanisms can be studied alongside gut barrier readouts. Aged tissue explant or senescent cell models — where GHK-Cu's anti-aging gene expression effects and KPV's NF-kB suppression may converge on inflammaging phenotypes. Ischemia-reperfusion injury models — where TB-500's cardiac and BPC-157's vascular mechanisms can be studied in combination for tissue protection research.

RESEARCH

What are the key red flags that indicate a peptide supplier does not meet research-grade standards?

Key red flags include: COAs provided without the actual HPLC chromatogram, purity claims without mass spectrometry identity confirmation, non-traceable or generic batch numbers, COAs that are generated on demand without per-lot documentation, unidentified testing laboratories, and purity claims that do not specify the analytical method used. Any of these gaps requires the lab to perform its own verification before using the material in research.